These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1978754)

  • 1. [Isotopic radioangiography in hepatic cirrhosis. Changes induced by somatostatin].
    Miguel F; Bóveda J; Solano D; Bilbao P; Martínez P; Franco R; de las Heras B; Bustamante V
    Rev Clin Esp; 1990 Jun; 187(2):61-4. PubMed ID: 1978754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
    Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
    Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
    Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
    Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic perfusion changes in patients with cirrhosis indices of hepatic arterial blood flow.
    Koranda P; Myslivecek M; Erban J; Seidlová V; Husák V
    Clin Nucl Med; 1999 Jul; 24(7):507-10. PubMed ID: 10402004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatostatin and ventricular function in liver cirrhosis].
    de la Villa FM; Solano López D; Bóveda J; Urrengoetxea J; Martínez Odriozola P; Bilbao Goitia P; Franco Vicario R
    Rev Clin Esp; 1990 Feb; 186(2):58-62. PubMed ID: 1970439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of hepatic and portal blood flow component with radionuclide angiography].
    Artiko VM
    Srp Arh Celok Lek; 1994; 122(5-6):152-4. PubMed ID: 17977414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A noninvasive method for measuring portal venous/total hepatic blood flow by hepatosplenic radionuclide angiography.
    Sarper R; Fajman WA; Rypins EB; Henderson JM; Tarcan YA; Galambos JT; Warren WD
    Radiology; 1981 Oct; 141(1):179-84. PubMed ID: 6270726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional liver circulation and scintigraphic imaging of portal circulation with 133Xe].
    Kroiss A
    Acta Med Austriaca Suppl; 1984; 31():1-28. PubMed ID: 6599830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angioscintigraphic assessment of arterial and portal liver blood flow: comparison with splanchnic angiography.
    Zatta G; Santambrogio R; Boccolari S; Mana O; Gattoni F; Baldini U; Galeotti F; Opocher E; Spina GP; Tarolo GL
    Nuklearmedizin; 1987 Apr; 26(2):83-6. PubMed ID: 3588322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The noninvasive assessment of the effects of penbutolol on liver hemodynamics in cirrhotic patients using angioscintigraphy. A randomized controlled double-blind study].
    Santambrogio R; Opocher E; Bruno S; Chiesa A; Gagliano G; Rossi S; Grugni MC; Zatta G; Bestetti A; Vignati L
    Recenti Prog Med; 1990 Nov; 81(11):705-9. PubMed ID: 1962892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The arterial haemodynamics of the liver and spleen in patients with cirrhosis of the liver (author's transl)].
    Lindenbraten LD; Filimonow GP; Savtschenko AP
    Rofo; 1977 Jul; 127(1):19-25. PubMed ID: 142729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of mesenteric and splenic blood flow in cirrhosis of the liver as estimated by radionuclide angiography.
    Hamato N; Moriyasu F; Someda H; Nabeshima M; Fujimoto M; Nishikawa K; Okuma M
    Intern Med; 1993 Jun; 32(6):445-8. PubMed ID: 8241587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "urea index" as a marker of portal flow direction in cirrhosis of the liver.
    Hazenberg HJ; Gips CH
    Acta Hepatogastroenterol (Stuttg); 1976 Apr; 23(2):93-100. PubMed ID: 1274521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regional liver circulation and the scintigraphic representation of the portal circulation with 133Xe].
    Kroiss A
    Acta Med Austriaca; 1984; 11(3-4):1-28. PubMed ID: 6475469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angioscintigraphic assessment of hemodynamic effects of penbutolol in cirrhotics with portal hypertension. A double-blind, randomized, controlled study.
    Santambrogio R; Bruno S; Opocher E; Galeotti F; Zatta G; Grugni M; Macri M; Pisani A; Tarolo G; Spina G
    Hepatogastroenterology; 1990 Aug; 37(4):398-402. PubMed ID: 2210607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatin.
    Barbare JC; Poupon R; Jaillon P; Bories P; Aussanaire M; Darnis F; Michel H; Cheymol G
    Hepatology; 1984; 4(1):59-62. PubMed ID: 6141135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver circulation.
    Viamonte M; Viamonte M
    CRC Crit Rev Clin Radiol Nucl Med; 1974; 5(3):351-87. PubMed ID: 4365422
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis.
    Hirooka M; Koizumi Y; Miyake T; Ochi H; Tokumoto Y; Tada F; Matsuura B; Abe M; Hiasa Y
    Radiology; 2015 Feb; 274(2):597-604. PubMed ID: 25302830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.